This capacity of LGR5 is reminiscent of brain-derived neurotrophic factor (BDNF)/tyrosine kinase receptor (TrkB) axis which has been shown to repress Bim via MEK/ERK phosphorylation [41] leading to increased resistance to chemotherapy in NB [42]. This evidence concerns the gene MAP2K7 and neuroblastoma.